Adjuvant Chemotherapy with Nanoparticle Albumin-Bound Paclitaxel and Carboplatin for Stage IB Non-small Cell Lung Cancer

被引：0
|
作者：
Motooka, Y. [1 ]
Matsuishi, K. [2 ]
Maruyama, R. [2 ]
Yoshimoto, K. [3 ]
Sakata, S. [1 ]
Aoki, M. [4 ]
Marutsuka, T. [5 ]
Tanaka, F. [6 ]
Suetsugu, T. [7 ]
Suzuki, M. [1 ]
机构：
[1] Kumamoto Univ Hosp, Kumamoto, Japan
[2] Omuta Tenryo Hosp, Omuta, Japan
[3] Minami Kyushu Hosp, Natl Hosp Org, Aira, Japan
[4] Kagoshima Univ, Sch Med, Kagoshima, Japan
[5] Kumamoto City Hosp, Kumamoto, Japan
[6] Univ Occupat & Environm Hlth, Kitakyushu, Fukuoka, Japan
[7] Kagoshima Univ, Kagoshima, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
early stage NSCLC; adjuvant chemotherapy; phase II multicenter clinical trial;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP07.02-10
引用
收藏
页码：S528 / S529
页数：2
相关论文
共 50 条
  • [21] Weekly nanoparticle albumin-bound paclitaxel and paclitaxel for relapsed small cell lung cancer A retrospective observational study
    Oi, Hajime
    Matsuda, Toshiaki
    Kimura, Tomoki
    Morise, Masahiro
    Yamano, Yasuhiko
    Yokoyama, Toshiki
    Kataoka, Kensuke
    Kondoh, Yasuhiro
    MEDICINE, 2022, 101 (06) : E28863
  • [22] Impact of adjuvant chemotherapy on outcomes in stage IB non-small cell lung cancer.
    Goyal, Gaurav
    Nawal, Lata
    Islam, K. M.
    Silberstein, Peter T.
    Ganti, Apar Kishor
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [23] Adjuvant Chemotherapy is Effective for Completely Resected Stage IB Non-Small Cell Lung Cancer
    Nakata, M.
    Nojima, Y.
    Nanba, K.
    Saisho, S.
    Shimizu, K.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S845 - S846
  • [24] Should Patients with Stage IB Non-Small Cell Lung Cancer Receive Adjuvant Chemotherapy?
    Wang, J.
    Nan, W.
    Lv, C.
    Yan, S.
    Yang, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S849 - S849
  • [25] Efficacy of Adjuvant Chemotherapy for Completely Resected Stage IB Non-Small Cell Lung Cancer
    Byun, M. K.
    Park, H. J.
    Park, H. S.
    Jeung, H.
    Cho, J. Y.
    Lee, S. S.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1982 - S1982
  • [26] Preoperative induction chemotherapy with weekly paclitaxel and carboplatin for clinical-stage IB-IIIA non-small cell lung cancer
    Tsuboi, M
    Ohira, T
    Hayashi, A
    Kajiwara, N
    Uchida, O
    LUNG CANCER, 2005, 49 : S175 - S175
  • [27] Efficacy of nanoparticle albumin-bound paclitaxel regimens for relapsed small cell lung cancer A retrospective analysis
    Naito, Yujiro
    Tamiya, Akihiro
    Tamiya, Motohiro
    Kimura, Yohei
    Hamaguchi, Masanari
    Saijo, Nobuhiko
    Kanazu, Masaki
    Tokura, Sayoko
    Shiroyama, Takayuki
    Morisita, Naoko
    Omachi, Naoki
    Suzuki, Hidekazu
    Okamoto, Norio
    Okishio, Kyoichi
    Hirashima, Tomonori
    Atagi, Shinji
    MEDICINE, 2017, 96 (35)
  • [28] The efficacy of carboplatin plus nanoparticle albumin-bound paclitaxel after cisplatin plus pemetrexed in non-squamous non-small-cell lung cancer patients
    Tanaka, Miho
    Hattori, Yoshihiro
    Ishii, Tatsuya
    Tohnai, Rie
    Itoh, Shoichi
    Kawa, Yoshitaka
    Kono, Yuko
    Urata, Yoshiko
    Satouchi, Miyako
    RESPIRATORY INVESTIGATION, 2020, 58 (04) : 269 - 274
  • [29] Induction paclitaxel/carboplatin in early stage non-small cell lung cancer
    Pisters, KMW
    Kris, MG
    Bunn, PA
    Johnson, DH
    Ruckdeschel, JC
    Crowley, JJ
    Ginsberg, RJ
    SEMINARS IN ONCOLOGY, 1997, 24 (04) : 41 - 44
  • [30] Influence of adjuvant chemotherapy on survival for patients with stage IB and IIA non-small cell lung cancer
    Zhang, Pei
    Duan, Jianchun
    Bai, Hua
    Wang, Zhijie
    Gao, Shugeng
    Tan, Fengwei
    Gao, Yushun
    Wang, Xin
    Wan, Rui
    Xu, Jiachen
    He, Xiran
    Feng, Xiaoshuang
    Yu, Ruofei
    Sun, Jing
    Zhao, Zhe
    Fei, Kailun
    Li, Ni
    He, Jie
    Wang, Jie
    THORACIC CANCER, 2021, 12 (01) : 30 - 39
12345